Aftercare in myopia management – progression and stabilisation - CooperVision

CPD ref: C-105291

Description

Myopia management was declared as a standard of care by the WCO in 2021 and supported by new guidance from the College of Optometrists in 2022 we are seeing in increase in the use of myopia control interventions globally as well as across Europe and in the UK&I. However the principle method given to the majority of young progressing myopes remains single vision correction only. As practitioners are seeing patients further into their myopia management journey questions are being asked about how to manage some of the findings in these “aftercare visits” as some patients, understandably, continue to progress despite being managed as well as those who appear to be stabilising and stop progressing under management.

Three cases will aim to explore some examples which may appear in any practice and overcome some of the concerns which may be raised by parents and carers as to whether the intervention is working or still necessary. A young myope continuing to worsen at their first aftercare the ECP now has additional options for management, should they change or continue with the current intervention? An older patient has already switched to a preferred strategy and progression is seen at the next visit what are the pros and cons of remaining in the current modality? A patient who is relatively new to the myopia management pathway appears to have stabilised and the parents are keen to move into conventional contact lenses for cost reasons.

Delegates will explore the conversations around these cases to understand the benefits and/or risks of remaining or changing myopia management strategy at a normal follow up appointment, and use up to date evidence-based technology tools to support their knowledge and communication.

Target audience

• Optometrist
• Dispensing Optician
• Contact Lens Optician.

Communication

• The ability to communicate to the patient about progression and stability whilst under myopia management. (S.2)
• An understanding of how to improve patient compliance with good communication and the impact of patent compliance on success. (S.2)
• The ability to effectively communicate with parents to maintain levels of expectation and review best options for the patient. (S.2).

Clinical Practice

• An understanding of the benefits and/or risks of remaining or changing the myopia management strategy at a normal follow up appointment. (S.7)
• The ability to use up to date evidence-based technology tools to support knowledge development. (S.5).

CLO Speciality

• An understanding of the benefits and/or risks of remaining or changing the myopia management strategy at a normal follow up appointment
• The ability to use up to date evidence-based technology tools to support knowledge development.